Novartis has announced plans to invest in a new Center for Advanced Cellular Therapies at the University of Pennsylvania in the US to research immunotherapies for patients with cancer using chimeric antigen receptor (CAR) technologies. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News Research & University News
